Enclomiphene in Tijuana

What is Enclomiphene?

Enclomiphene citrate is the trans-isomer of clomiphene citrate, refined to provide pure estrogen receptor modulation without the mixed agonist-antagonist activity of its parent compound. Originally developed as a fertility drug under the brand name Androxal, enclomiphene has become a cornerstone therapy for men with secondary hypogonadism who want to raise testosterone naturally without compromising fertility.

Unlike injectable testosterone replacement therapy (TRT), which suppresses the hypothalamic-pituitary-gonadal (HPG) axis and shuts down endogenous testosterone production, enclomiphene actively stimulates LH and FSH release. This cascade prompts the testes to produce more testosterone and sperm on their own, making enclomiphene ideal for men who want symptom relief without the fertility, testicular, and dependency concerns associated with TRT.

Enclomiphene Protocols Available

Contraindications and Safety Information

Enclomiphene is contraindicated in men with primary hypogonadism, untreated prolactinoma, prostate cancer, breast cancer, severe liver disease, or known hypersensitivity to clomiphene. Patients on testosterone replacement should discontinue TRT and complete a washout period before starting enclomiphene. Regular monitoring of total testosterone, estradiol, hematocrit, and PSA is required throughout therapy. Always disclose all current medications and supplements to your physician.

At Vive Med Spa, enclomiphene therapy is supervised by board-certified physicians following NOM-241-SSA-2020 guidelines for clinical research and medical practice. Each patient receives a personalized protocol with mandatory baseline labs and follow-up testing at 6 and 12 weeks.